enVVeno Medical Corp SEC filings NVNO

enVVeno Medical Corp has 415 filings in SEC EDGAR's recent list, going back to Dec 15, 2015. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

enVVeno Medical Corp SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Oct 29, 2026 —
DEF 14A Proxy statement Oct 29, 2026 Dec 10, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
S-3 Shelf registration Aug 21, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 29, 2026 Apr 29, 2026
S-8 Employee stock plan registration Mar 26, 2026 —
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Other events
Feb 4, 2026 Feb 4, 2026
8-K Current report
Bylaw or fiscal year change
Jan 20, 2026 Jan 20, 2026
8-K Current report
Shareholder vote results
Dec 12, 2025 Dec 11, 2025
DEFR14A Filing Dec 2, 2025 —
8-K Current report
Bylaw or fiscal year change
Nov 20, 2025 Nov 17, 2025
PRER14A Filing Nov 19, 2025 —
8-K Current report
Regulation FD disclosure
Nov 14, 2025 Nov 13, 2025
8-K Current report
Material agreement
Oct 30, 2025 Oct 30, 2025
424B5 Prospectus supplement Oct 30, 2025 —
DEFA14A Additional proxy material Oct 30, 2025 —
DEF 14A Proxy statement Oct 30, 2025 Dec 11, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Listing notice
Oct 10, 2025 Oct 7, 2025
8-K Current report
Regulation FD disclosure
Aug 20, 2025 Aug 20, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Officer or director change
May 20, 2025 May 19, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Auditor change
Apr 21, 2025 Apr 17, 2025
EFFECT Filing Mar 14, 2025 —
CORRESP Letter to the SEC Mar 14, 2025 —
S-8 Employee stock plan registration Mar 12, 2025 —
S-3/A Filing Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 10, 2025 —
S-3 Shelf registration Feb 28, 2025 —
10-K/A Amended annual report Feb 28, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
Dec 26, 2024 Dec 18, 2024
DEF 14A Proxy statement Nov 19, 2024 Dec 18, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Material agreement
Sep 30, 2024 Sep 26, 2024
424B5 Prospectus supplement Sep 30, 2024 —
FWP Free writing prospectus Sep 27, 2024 —
424B5 Prospectus supplement Sep 26, 2024 —
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
S-8 Employee stock plan registration May 10, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
Apr 24, 2024 Apr 24, 2024
8-K Current report
Regulation FD disclosure
Mar 6, 2024 Mar 6, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Shareholder vote results
Dec 7, 2023 Dec 5, 2023
8-K Current report
Regulation FD disclosure
Nov 16, 2023 Nov 16, 2023
EFFECT Filing Nov 3, 2023 —
DEF 14A Proxy statement Nov 3, 2023 Nov 3, 2023
CORRESP Letter to the SEC Nov 1, 2023 —
UPLOAD Letter from the SEC Oct 31, 2023 —
S-3 Shelf registration Oct 26, 2023 —
10-Q Quarterly report Oct 26, 2023 Sep 30, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 12, 2023 Oct 6, 2023
EFFECT Filing Aug 23, 2023 —
CORRESP Letter to the SEC Aug 21, 2023 —
S-3/A Filing Aug 14, 2023 —
UPLOAD Letter from the SEC Aug 7, 2023 —
S-3 Shelf registration Jul 31, 2023 —
10-Q Quarterly report Jul 31, 2023 Jun 30, 2023
25-NSE Delisting notice May 26, 2023 —
424B3 Prospectus May 5, 2023 —
10-Q Quarterly report Apr 28, 2023 Mar 31, 2023
10-K Annual report Mar 2, 2023 Dec 31, 2022
8-K Current report
Shareholder vote results
Dec 6, 2022 Nov 30, 2022
DEF 14A Proxy statement Nov 1, 2022 Nov 1, 2022
10-Q Quarterly report Oct 27, 2022 Sep 30, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
UPLOAD Letter from the SEC May 16, 2022 —
10-Q/A Amended quarterly report May 11, 2022 Mar 31, 2022
10-K/A Amended annual report May 11, 2022 Dec 31, 2021
CORRESP Letter to the SEC May 11, 2022 —
UPLOAD Letter from the SEC May 6, 2022 —
10-Q Quarterly report Apr 29, 2022 Mar 31, 2022
S-8 Employee stock plan registration Apr 18, 2022 —
10-K Annual report Mar 28, 2022 Dec 31, 2021
8-K/A Amended current report
Shareholder vote results
Dec 3, 2021 Nov 30, 2021
8-K Current report
Shareholder vote results, Regulation FD disclosure
Dec 1, 2021 Nov 30, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
DEF 14A Proxy statement Nov 2, 2021 Nov 1, 2021
8-K Current report
Bylaw or fiscal year change
Oct 1, 2021 Sep 29, 2021
8-K Current report
Other events
Sep 22, 2021 Sep 21, 2021
8-K Current report
Material agreement
Sep 8, 2021 Sep 3, 2021
424B5 Prospectus supplement Sep 8, 2021 —
8-K Current report
Material agreement
Aug 12, 2021 Aug 12, 2021
424B5 Prospectus supplement Aug 12, 2021 —
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
424B3 Prospectus Aug 6, 2021 —
S-8 Employee stock plan registration May 26, 2021 —
10-Q Quarterly report May 12, 2021 Mar 31, 2021
EFFECT Filing May 6, 2021 —
POS AM Filing Apr 30, 2021 —
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Feb 24, 2021 Feb 18, 2021
8-K Current report
Material agreement, Other events
Feb 12, 2021 Feb 12, 2021
424B4 Prospectus Feb 10, 2021 —
EFFECT Filing Feb 8, 2021 —
S-1MEF Filing Feb 8, 2021 —
CORRESP Letter to the SEC Feb 5, 2021 —
CORRESP Letter to the SEC Feb 5, 2021 —
FWP Free writing prospectus Feb 5, 2021 —
S-1/A Amended registration statement Feb 5, 2021 —
CORRESP Letter to the SEC Feb 4, 2021 —
CORRESP Letter to the SEC Feb 3, 2021 —
CORRESP Letter to the SEC Feb 3, 2021 —
S-1/A Amended registration statement Feb 3, 2021 —
FWP Free writing prospectus Jan 29, 2021 —
S-1/A Amended registration statement Jan 28, 2021 —
UPLOAD Letter from the SEC Dec 28, 2020 —
8-K Current report
Shareholder vote results, Other events
Dec 21, 2020 Dec 17, 2020
S-1 Registration statement Dec 21, 2020 —
8-K Current report
Bylaw or fiscal year change
Dec 2, 2020 Nov 30, 2020
EFFECT Filing Nov 30, 2020 —
CORRESP Letter to the SEC Nov 27, 2020 —
8-K Current report
Unregistered share sale
Nov 24, 2020 Nov 24, 2020
S-1/A Amended registration statement Nov 24, 2020 —
10-Q Quarterly report Nov 17, 2020 Sep 30, 2020
NT 10-Q Filing Nov 17, 2020 Sep 30, 2020
DEF 14A Proxy statement Nov 13, 2020 Nov 13, 2020
UPLOAD Letter from the SEC Nov 12, 2020 —
S-1 Registration statement Nov 6, 2020 —
EFFECT Filing Oct 22, 2020 —
CORRESP Letter to the SEC Oct 20, 2020 —
424B5 Prospectus supplement Oct 8, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Oct 8, 2020 Oct 7, 2020
S-3/A Filing Oct 5, 2020 —
UPLOAD Letter from the SEC Sep 24, 2020 —
S-3 Shelf registration Sep 17, 2020 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Sep 16, 2020 Sep 15, 2020
DEFA14A Additional proxy material Aug 19, 2020 —
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
UPLOAD Letter from the SEC Aug 13, 2020 —
DEF 14A Proxy statement Aug 12, 2020 Aug 12, 2020
CORRESP Letter to the SEC Aug 10, 2020 —
UPLOAD Letter from the SEC Aug 10, 2020 —
D Filing Aug 4, 2020 —
PRE 14A Preliminary proxy statement Jul 24, 2020 Jul 23, 2020
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jul 21, 2020 Jul 17, 2020
424B4 Prospectus Jul 20, 2020 —
EFFECT Filing Jul 16, 2020 —
S-1/A Amended registration statement Jul 16, 2020 —
CORRESP Letter to the SEC Jul 15, 2020 —
CORRESP Letter to the SEC Jul 15, 2020 —
FWP Free writing prospectus Jul 13, 2020 —
S-1/A Amended registration statement Jul 13, 2020 —
UPLOAD Letter from the SEC Jul 8, 2020 —
S-1 Registration statement Jul 2, 2020 —
EFFECT Filing Jun 23, 2020 —
CORRESP Letter to the SEC Jun 22, 2020 —
UPLOAD Letter from the SEC Jun 19, 2020 —
S-1 Registration statement Jun 15, 2020 —
8-K Current report
Other events
Jun 15, 2020 Jun 15, 2020
10-Q Quarterly report Jun 8, 2020 Mar 31, 2020
8-K Current report
Material agreement, Unregistered share sale
Jun 3, 2020 Jun 1, 2020
424B5 Prospectus supplement Jun 3, 2020 —
8-K Current report
Other events
May 15, 2020 May 15, 2020
8-K Current report
Material agreement, Unregistered share sale
Apr 28, 2020 Apr 24, 2020
424B5 Prospectus supplement Apr 28, 2020 —
8-K Current report
Listing notice
Apr 20, 2020 Apr 14, 2020
EFFECT Filing Apr 16, 2020 —
CORRESP Letter to the SEC Apr 15, 2020 —
UPLOAD Letter from the SEC Apr 14, 2020 —
8-K Current report
Officer or director change
Apr 10, 2020 Apr 6, 2020
S-3 Shelf registration Apr 7, 2020 —
8-K Current report
Officer or director change
Apr 3, 2020 Mar 30, 2020
8-K Current report
Listing notice
Mar 25, 2020 Mar 20, 2020
10-K Annual report Mar 18, 2020 Dec 31, 2019
D Filing Mar 10, 2020 —
8-K Current report
Unregistered share sale
Mar 2, 2020 Feb 25, 2020
8-K Current report
Shareholder vote results
Dec 11, 2019 Dec 6, 2019
10-Q Quarterly report Oct 31, 2019 Sep 30, 2019
DEF 14A Proxy statement Oct 29, 2019 Oct 28, 2019
8-K Current report
Regulation FD disclosure
Oct 25, 2019 Oct 24, 2019
8-K Current report
Listing notice
Oct 18, 2019 Oct 14, 2019
8-K Current report
Officer or director change
Sep 17, 2019 Sep 13, 2019
10-Q Quarterly report Aug 5, 2019 Jun 30, 2019
8-K Current report
Officer or director change
Aug 1, 2019 Aug 1, 2019
8-K Current report
Regulation FD disclosure
Jul 26, 2019 Jul 26, 2019
424B4 Prospectus Jun 13, 2019 —
EFFECT Filing Jun 11, 2019 —
CORRESP Letter to the SEC Jun 10, 2019 —
S-1 Registration statement Jun 7, 2019 —
8-K Current report
Other events
Jun 7, 2019 Jun 7, 2019
UPLOAD Letter from the SEC May 28, 2019 —
8-K Current report
Officer or director change
May 24, 2019 May 23, 2019
UPLOAD Letter from the SEC May 21, 2019 —
DRS Filing May 15, 2019 —
10-Q Quarterly report May 9, 2019 Mar 31, 2019
424B3 Prospectus May 7, 2019 —
EFFECT Filing May 6, 2019 —
D/A Filing May 3, 2019 —
POS AM Filing May 1, 2019 —
8-K Current report
Listing notice
Apr 30, 2019 Apr 30, 2019
EFFECT Filing Apr 29, 2019 —
CORRESP Letter to the SEC Apr 25, 2019 —
D Filing Apr 16, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NVNO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661053
Former names
Hancock Jaffe Laboratories, Inc. (until Sep 22, 2021)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.